🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT05994976
Recruiting Observational

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

NCT05994976 · tracked via the Priya Life Science Canada tracker
Sponsor
Innovaderm Research Inc
Phase
Observational
Started
2023-10-17
Last updated
2026-03-30

Condition(s) studied

AcneAtopic DermatitisChronic Hand EczemaHidradenitis SuppurativaPlaque PsoriasisPalmoplantar Pustulosis

Investigational drug(s) / intervention(s)

Blood samples collectionOral samples collectionHair samples collectionSkin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)Skin surface material samplesDrainage fluid samples collectionStool samples collection

Blood samples collection: biomarkers and optional genetic analysis

Oral samples collection: biomarkers analysis

Hair samples collection: biomarkers analysis

Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping): biomarkers analysis

Skin surface material samples: biomarkers analysis

Drainage fluid samples collection: biomarkers analysis

Stool samples collection: biomarkers analysis

Study summary

The purpose of the study is to collect different samples for molecular characterization of inflammatory skin diseases.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: All subjects: 1. Subject is willing to participate and is capable of giving informed consent. Note: Consent must be obtained prior to any study-related procedures. 2. Subject must be willing to comply with all study procedures and must be available for the duration of the study. Healthy volunteers: 3. Male or female subject aged 18 years or older, at the time of consent. 4. Subject is in good general health, according to the investigator's judgment. Subjects with Acne: 5. Male or female subject aged 18 to 45 years old, inclusive, at the time of consent. Subjects with AD: 6. Male or female subject aged 18 years or older, at the time of consent. 7. Subject has clinically confirmed diagnosis of active AD, according to Hanifin and Rajka criteria. Subjects with CHE: 8. Male or female subject aged 18 years or older, at the time of consent. 9. Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject). Subjects with HS: 10. Male or female subject aged 18 years or older, at the time of consent. 11. Subject has a clinically confirmed diagnosis of active HS with a disease duration of ≥ 6 months before screening as determined by the investigator through subject interview and/or review of the medical history. Subjects with PPP: 12. Male or female subject aged 18 years or older at the time of consent. 13. Subject has at least a 6-month history of PPP as defined by the presence of pustules on palms and/or soles, but without evidence of infection on palms and soles (information obtained from medical chart or subject's physician, or directly from the subject). Subjects with psoriasis: 14. Male or female subject aged 18 years or older, at the time of consent. Exclusion Criteria: All subjects: 1. Subject is a female who is pregnant or who is planning to become pregnant during the study. 2. Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Innovaderm Research Inc. Montreal Quebec Recruiting

More Innovaderm Research Inc. trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05994976 on ClinicalTrials.gov ↗ ← All trials in Canada